Company profile · Biotech & medical
Abnova（Taiwan）
亞諾法生技股份有限公司 · 4133
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Abnova manufactures antibodies, including monoclonal antibodies, polyclonal antibodies, and recombinant antibodies, as well as proteins, medical testing instruments, and diagnostic reagents.[1]
The company also offers customized proteins and antibodies, cell lysate preparation, kits, fluorescent dyes, DNA and RNA probes, tissue slides, beads, pseudoviruses, laboratory disposable reagents, and various separation, extraction, and imaging systems.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$32m | +19.1% | +30.9% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$2m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Abnova（Taiwan）Corporation |
|---|---|
| Chinese name | 亞諾法生技股份有限公司 |
| Stock code | 4133 (TWSE) |
| Industry | Biotech & medical |
| Founded | 04 Jan 2002 |
| Listed | 28 Dec 2009 |
| Paid-in capital | NT$606m |
| Chairman | 黃韋伯 |
| President | 紀姵如 |
| Headquarters | 9F, NO.108, Jhouzih St, Neihu Taipei Taiwan |
| Website | http://www.abnova.com |
| Official business description | 單株抗體、多株抗體、蛋白質、醫療檢測儀器及檢驗試劑 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 亞諾法生技股份有限公司 · mops · retrieved 04 Nov 2026
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list